B
Black Diamond Therapeutics D
D
BDTX
2.56500
USD
0.11
(4.27%)
Market Closed
Volume
14,374
EPS
-1
Div Yield
-
P/E
-2
Market Cap
145,140,687
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks news More
Title: Black Diamond Therapeutics
Sector: Healthcare
Industry: Biotechnology
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.